Client News

Carbios announces half-year 2023 financial results and corporate update

Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

Destiny Pharma: Destiny Pharma: Notice of XF Pipeline Update Meeting

Abivax presents first-half 2023 financial results

Destiny Pharma: Interim results for the six months ended 30 June 2023

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference

Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer

Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library